| Comparative cost-effectiveness of conservative or intensive blood pressure treatment guidelines in adults aged 35–74 years: the cardiovascular disease policy model N Moise, C Huang, A Rodgers, CN Kohli-Lynch, KY Tzong, PG Coxson, ... Hypertension 68 (1), 88-96, 2016 | 54 | 2016 |
| Cost-effectiveness of low-density lipoprotein cholesterol level–guided statin treatment in patients with borderline cardiovascular risk CN Kohli-Lynch, BK Bellows, G Thanassoulis, Y Zhang, MJ Pletcher, ... JAMA cardiology 4 (10), 969-977, 2019 | 43 | 2019 |
| Long-term weight loss trajectories following participation in a randomised controlled trial of a weight management programme for men delivered through professional football … CM Gray, S Wyke, R Zhang, AS Anderson, S Barry, N Boyer, G Brennan, ... International Journal of Behavioral Nutrition and Physical Activity 15, 1-13, 2018 | 38 | 2018 |
| The clinical utility of apoB versus LDL-C/non-HDL-C CN Kohli-Lynch, G Thanassoulis, AE Moran, AD Sniderman Clinica chimica acta 508, 103-108, 2020 | 37 | 2020 |
| Long-term weight loss following a randomised controlled trial of a weight management programme for men delivered through professional football clubs: the Football Fans in … CM Gray, S Wyke, R Zhang, AS Anderson, S Barry, G Brennan, A Briggs, ... Public health research 6 (9), 2018 | 35 | 2018 |
| Cost-effectiveness of lipid-lowering treatments in young adults CN Kohli-Lynch, BK Bellows, Y Zhang, B Spring, DS Kazi, MJ Pletcher, ... Journal of the American College of Cardiology 78 (20), 1954-1964, 2021 | 34 | 2021 |
| Estimating the healthcare cost of overweight and obesity in South Africa MK Boachie, E Thsehla, M Immurana, C Kohli-Lynch, KJ Hofman Global Health Action 15 (1), 2045092, 2022 | 28 | 2022 |
| Hypertension in the South African public healthcare system: a cost-of-illness and burden of disease study CN Kohli-Lynch, A Erzse, BL Rayner, KJ Hofman BMJ open 12 (2), e055621, 2022 | 25 | 2022 |
| A cost-effectiveness analysis of South Africa’s seasonal influenza vaccination programme I Edoka, C Kohli-Lynch, H Fraser, K Hofman, S Tempia, M McMorrow, ... Vaccine 39 (2), 412-422, 2021 | 23 | 2021 |
| Beyond 10-year risk: a cost-effectiveness analysis of statins for the primary prevention of cardiovascular disease CN Kohli-Lynch, J Lewsey, KA Boyd, DD French, N Jordan, AE Moran, ... Circulation 145 (17), 1312-1323, 2022 | 18 | 2022 |
| Heterogeneity in cost-effectiveness analysis CN Kohli-Lynch, AH Briggs Oxford Research Encyclopedia of Economics and Finance, 2019 | 13 | 2019 |
| Trial-based economic evaluations of supported employment for adults with severe mental illness: a systematic review K Zheng, BZ Stern, QE Wafford, CN Kohli-Lynch Administration and Policy in Mental Health and Mental Health Services …, 2022 | 11 | 2022 |
| From spreadsheets to script: experiences from converting a Scottish cardiovascular disease policy model into R Y Xin, E Gray, JA Robles-Zurita, H Haghpanahan, R Heggie, ... Applied health economics and health policy, 1-10, 2022 | 7 | 2022 |
| Costs of seasonal influenza vaccination in South Africa H Fraser, W Tombe‐Mdewa, C Kohli‐Lynch, K Hofman, S Tempia, ... Influenza and other respiratory viruses 16 (5), 873-880, 2022 | 6 | 2022 |
| Projecting the fiscal impact of South Africa’s contraceptive needs: Scaling up family planning post 2020 L Chola, K MacQuilkan, A Winch, R Rapiti, I Edoka, C Kohli-Lynch, ... South African Medical Journal 109 (10), 756-760, 2019 | 6 | 2019 |
| Probabilistic sensitivity analysis and value of information analysis CN Kohli-Lynch Handbook of Applied Health Economics in Vaccines, 290, 2023 | 4 | 2023 |
| Cost-effectiveness of masked hypertension screening and treatment in US adults with suspected masked hypertension: a simulation study MB Green, D Shimbo, JE Schwartz, AP Bress, JB King, P Muntner, ... American Journal of Hypertension 35 (8), 752-762, 2022 | 4 | 2022 |
| The Causal-Benefit Model to Prevent Cardiovascular Events C Kohli-Lynch, G Thanassoulis, M Pencina, D Sehayek, K Pencina, ... JACC: Advances 3 (3), 100825, 2024 | 2 | 2024 |
| Extended cost-effectiveness analysis of interventions to improve uptake of diabetes services in South Africa HL Fraser, I Feldhaus, IP Edoka, AN Wade, CN Kohli-Lynch, K Hofman, ... Health Policy and Planning 39 (3), 253-267, 2024 | 1 | 2024 |
| An Economic Evaluation of Non-HDL-Cholesterol and Apolipoprotein B as Treatment Targets for Lipid-Lowering Therapy in Primary Prevention S Luebbe, J Wilkins, A Moran, A Sniderman, C Kohli-Lynch Circulation 150 (Suppl_1), A4142200-A4142200, 2024 | | 2024 |
